Clinical Trials Directory

Trials / Completed

CompletedNCT01519232

A Study of Changes in Hepatic Function During Radiation Therapy Using Hepatobiliary Single Photon Emission Tomography (SPECT)

A Pilot Study of Changes in Hepatic Function During Radiation Therapy Using Hepatobiliary SPECT

Status
Completed
Phase
Study type
Observational
Enrollment
23 (actual)
Sponsor
University of Michigan Rogel Cancer Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Radiation-induced liver disease (RILD) is a syndrome characterized by the development of anicteric ascites approximately 2 weeks to 4 months after hepatic irradiation. Previous studies have shown that both the volume of liver irradiated and the dose of radiation delivered are prominent factors for development of RILD. While use of a population-based normal tissue complication probability model allows investigators to limit the risk of RILD to a clinically acceptable level, a test that permits investigators to determine an individual's risk of RILD during the course of treatment may allow for individualized treatment modifications, either to prevent toxicity or increase efficacy.

Detailed description

Early, but subclinical physiologic changes in the liver may be associated with the future development of RILD. There are currently limited data on how a local change in hepatic function associates with regional radiation dose, and how the change of hepatic function during and after radiation therapy (RT) associates with RILD. In the present study, a radiological methodology that is minimally invasive will be used to measure volumetric hepatic functions in patients with intrahepatic malignancies before, during, and after a course of fractioned radiation therapy.

Conditions

Interventions

TypeNameDescription
RADIATIONLiver IrradiationPatients already scheduled to undergo radiation treatment

Timeline

Start date
2008-08-01
Primary completion
2012-06-01
Completion
2014-05-01
First posted
2012-01-26
Last updated
2015-05-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01519232. Inclusion in this directory is not an endorsement.